Stopping Atherosclerosis and Treating Unhealthy bone with RosuvastatiN in HIV ( SATURN-HIV ) is a randomized , double-blind placebo-controlled trial assessing the effect of rosuvastatin ( @ mg daily ) on markers of cardiovascular risk and immune activation in ART-treated patients .